Devices for intradermal vaccination

被引:73
作者
Kis, Elsa E. [1 ]
Winter, Gerhard [1 ]
Myschik, Julia [1 ]
机构
[1] Univ Munich, Dept Pharm, Dept Pharm Pharmaceut Technol & Biopharmaceut, D-81377 Munich, Germany
关键词
Intradermal vaccination; Microinjection; Microneedle; Liquid jet injection; Ballistic injection; B SURFACE-ANTIGEN; EPIDERMAL POWDER IMMUNIZATION; SEASONAL INFLUENZA VACCINE; VIRUS-LIKE PARTICLES; INACTIVATED POLIOVIRUS VACCINE; FREE JET INJECTIONS; TRANSCUTANEOUS IMMUNIZATION; TRANSDERMAL DELIVERY; DNA VACCINE; ANTIBODY-RESPONSES;
D O I
10.1016/j.vaccine.2011.11.020
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
New insights in vaccine development, the need for safe, economic and efficient vaccine administration and the increasing mechanistic knowledge of immune responses induced by targeting the intradermal layers of the skin have all driven the engineering of devices for intradermal vaccination. In this review we highlight different delivery devices that make the epidermal and dermal layers of the skin accessible for vaccine administration. Depending on the device the desired vaccine can be applied either as a liquid formulation or as solid, powdered vaccine particles. The process of intradermal injection employs micron-sized needles that are inserted 1.5 mm perpendicularly into the skin, and which inject approximately 100-200 mu l of a liquid vaccine formulation into the dermal skin layers. Tattoo devices, on the other hand, can be used to deliver liquid vaccine formulations into the dermal layer of the skin by the use of oscillating needles. Microneedle arrays are made of vaccine-coated solid microneedles or biodegradable microneedles. These are inserted into the dermal layers of the skin where either the vaccine coating is dissolved, or the microneedle itself dissolves in place. Jet-injectors operate by generating a high pressured stream, which flushes the liquid vaccine formulation into the deeper skin layers. Delivery devices using liquid vaccine formulations are advantageous, as established vaccine formulations can be used as provided without the need for reformulation. However, approaches that deliver vaccines in a solid form may also prove to be promising. One such method is the ballistic approach, in which solid vaccine particles or vaccine-coated gold particles are accelerated towards the skin by needle-free devices, so that the particles are deposited in the epidermal and dermal layers of the skin. These various delivery devices are explored in this review with regard to their delivery mechanism and ease of handling, their efficacy in clinical trials and their suitability for practical use. (C) 2011 Elsevier Ltd. All rights reserved.
引用
收藏
页码:523 / 538
页数:16
相关论文
共 208 条
[21]   Studies on the use of needle-free injection device on proteins [J].
Benedek, K ;
Walker, E ;
Doshier, LA ;
Stout, R .
JOURNAL OF CHROMATOGRAPHY A, 2005, 1079 (1-2) :397-407
[22]   PREEXPOSURE IMMUNIZATION WITH INTRADERMAL HUMAN-DIPLOID CELL RABIES VACCINE - RISKS AND BENEFITS OF PRIMARY AND BOOSTER VACCINATION [J].
BERNARD, KW ;
MALLONEE, J ;
WRIGHT, JC ;
REID, FL ;
MAKINTUBEE, S ;
PARKER, RA ;
DWYER, DM ;
WINKLER, WG .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1987, 257 (08) :1059-1063
[23]   A rapid and potent DNA vaccination strategy defined by in vivo monitoring of antigen expression [J].
Bins, AD ;
Jorritsma, A ;
Wolkers, MC ;
Hung, CF ;
Wu, TC ;
Schumacher, TNM ;
Haanen, JBAG .
NATURE MEDICINE, 2005, 11 (08) :899-904
[24]   Enabling topical immunization via microporation: a novel method for pain-free and needle-free delivery of adenovirus-based vaccines [J].
Bramson, J ;
Dayball, K ;
Evelegh, C ;
Wan, YH ;
Page, D ;
Smith, A .
GENE THERAPY, 2003, 10 (03) :251-260
[25]  
Bricks Lucia F., 2004, J. Pediatr. (Rio J.), V80, P93, DOI 10.1590/S0021-75572004000200004
[26]   IMMUNIZING EFFECT OF INFLUENZA A-NEW-JERSEY-76 (HSW1N1) VIRUS-VACCINE ADMINISTERED INTRADERMALLY AND INTRAMUSCULARLY TO ADULTS [J].
BROWN, H ;
KASEL, JA ;
FREEMAN, DM ;
MOISE, LD ;
GROSE, NP ;
COUCH, RB .
JOURNAL OF INFECTIOUS DISEASES, 1977, 136 :S466-S471
[27]   PERSISTENCE OF ANTIBODY TO HEPATITIS-B SURFACE-ANTIGEN AFTER LOW-DOSE, INTRADERMAL HEPATITIS-B IMMUNIZATION AND RESPONSE TO A BOOSTER DOSE [J].
BRYAN, JP ;
SJOGREN, MH ;
MACARTHY, P ;
COX, E ;
LEGTERS, LJ ;
PERINE, PL .
VACCINE, 1992, 10 (01) :33-38
[28]   Transdermal and transmucosal powdered drug delivery [J].
Burkoth, TL ;
Bellhouse, BJ ;
Hewson, G ;
Longridge, DJ ;
Muddle, AG ;
Sarphie, DF .
CRITICAL REVIEWS IN THERAPEUTIC DRUG CARRIER SYSTEMS, 1999, 16 (04) :331-384
[29]   Rapid Intradermal Delivery of Liquid Formulations Using a Hollow Microstructured Array [J].
Burton, Scott A. ;
Ng, Chin-Yee ;
Simmers, Ryan ;
Moeckly, Craig ;
Brandwein, David ;
Gilbert, Tom ;
Johnson, Nathan ;
Brown, Ken ;
Alston, Tesha ;
Prochnow, Gayatri ;
Siebenaler, Kris ;
Hansen, Kris .
PHARMACEUTICAL RESEARCH, 2011, 28 (01) :31-40
[30]   Enhancing immunogenicity and reducing dose of microparticulated synthetic vaccines:: Single intradermal administration [J].
Carcaboso, AM ;
Hernández, RM ;
Igartua, M ;
Rosas, JE ;
Patarroyo, ME ;
Pedraz, JL .
PHARMACEUTICAL RESEARCH, 2004, 21 (01) :121-126